MTOR and lung carcinoma: Furthermore, the Akt/mTOR signaling pathway is frequently altered in certain types of cancer, including gastric cancer, prostate cancer, cervical carcinoma, renal cell carcinoma, lung carcinoma and pancreatic ductal adenocarcinoma (21–25).